An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma

JOURNAL ARTICLE published July 2011 in Annals of Oncology

Authors: T.E. Witzig | J.M. Vose | P.L. Zinzani | C.B. Reeder | R. Buckstein | J.A. Polikoff | R. Bouabdallah | C. Haioun | H. Tilly | P. Guo | D. Pietronigro | A.L. Ervin-Haynes | M.S. Czuczman